Based on previous studies done in mice, researchers observed that GLP-1 agonists/DPP-4 inhibitors work to reduce inflammation in the gut, so they proposed that the same mechanism may occur in humans (5, 6)
Nature 450 , 887892 (2007)
Consequently, competition in the Chinese GLP-1 market is expected to become increasingly intense
Frequently Asked Questions What is the primary difference in the 5-Amino-1MQ vs LIPO-C debate
Pooled estimates were calculated with the random-effects model, considering that the patients came from different populations
Intravenous (IV) therapy is a medical treatment that involves administering fluids, nutrients, and medications directly into a patients bloodstream through a vein